Orgametril (Lynestrenol)

Lynestrenol, the active ingredient in Orgametril, is a progestogen presented as an oral tablet for oral use. It is employed as a hormonal contraceptive to prevent pregnancy in women of reproductive age.

GNH USA supplies Orgametril as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Orgametril, containing the progestogen lynestrenol, is used within hormonal contraceptive regimens to prevent pregnancy. - Contraception: prevents ovulation and implantation, providing reliable birth control. - Menstrual cycle regulation: helps achieve more predictable menstrual bleeding when used in combination therapy. - Endometrial protection: induces changes in the uterine lining that reduce the risk of breakthrough bleeding.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: transient tension‑type headaches. - Breast tenderness: mild discomfort or swelling. - Weight gain: modest increase in body weight. - Mood changes: occasional irritability or mood swings. - Spotting: irregular light bleeding.

Serious or Rare Side Effects: - Venous thromboembolism: deep vein thrombosis or pulmonary embolism. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Liver dysfunction: jaundice or elevated liver enzymes.

Before initiating therapy, consider the following precautions: - Thrombotic risk assessment: evaluate personal or family history of clotting disorders. - Liver function review: avoid use in patients with active liver disease. - Smoking status: counsel smokers, especially over age 35, about increased cardiovascular risk. - Medication review: check for drugs that may reduce contraceptive efficacy. - Pregnancy avoidance: do not use during pregnancy; use alternative contraception if pregnancy is confirmed. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Lynestrenol may interact with several medications, requiring careful management. Major Interactions (Avoid): - Enzyme inducers (e.g., rifampicin): may markedly reduce contraceptive effectiveness. - Strong antifungals (e.g., ketoconazole): can increase hormone levels, raising side‑effect risk. - Protease inhibitors (e.g., ritonavir): may alter metabolism and efficacy. Moderate Interactions (Monitor Closely): - Anticonvulsants (e.g., phenytoin): may lower plasma concentrations. - St. John’s wort: may decrease contraceptive reliability. - Certain antibiotics (e.g., erythromycin): may modestly affect hormone levels.